Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine
Gaetano Giuffrida,
Annalisa Condorelli,
Mary Ann Di Giorgio,
Uros Markovic,
Roberta Sciortino,
Daniela Nicolosi,
Francesco Di Raimondo
Affiliations
Gaetano Giuffrida
Division of Hematology, AOU "Policlinico G. Rodolico-San Marco", Via Santa Sofia 78, 95124 Catania
Annalisa Condorelli
Division of Hematology, AOU "Policlinico G. Rodolico-San Marco", Via Santa Sofia 78, 95124 Catania, Italy; Postgraduate School of Hematology, University of Catania
Mary Ann Di Giorgio
Division of Hematology, AOU "Policlinico G. Rodolico-San Marco", Via Santa Sofia 78, 95124 Catania, Italy; Postgraduate School of Hematology, University of Catania
Uros Markovic
Division of Hematology, AOU "Policlinico G. Rodolico-San Marco", Via Santa Sofia 78, 95124 Catania, Italy; Unità Operativa di Oncoematologia e BMT Unit, Istituto Oncologico del Mediterraneo, Viagrande
Roberta Sciortino
Division of Hematology, AOU "Policlinico G. Rodolico-San Marco", Via Santa Sofia 78, 95124 Catania, Italy; Postgraduate School of Hematology, University of Catania
Daniela Nicolosi
Division of Hematology, AOU "Policlinico G. Rodolico-San Marco", Via Santa Sofia 78, 95124 Catania
Francesco Di Raimondo
Division of Hematology, AOU "Policlinico G. Rodolico-San Marco", Via Santa Sofia 78, 95124 Catania
